OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide ‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database
Matthew Anson, Alex E. Henney, Sizheng Steven Zhao, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2606-2623
Closed Access | Times Cited: 8
Matthew Anson, Alex E. Henney, Sizheng Steven Zhao, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2606-2623
Closed Access | Times Cited: 8
Showing 8 citing articles:
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 23
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 23
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 4
Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 4
GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?
Abdelilah Arredouani
Pharmacology & Therapeutics (2025), pp. 108824-108824
Closed Access
Abdelilah Arredouani
Pharmacology & Therapeutics (2025), pp. 108824-108824
Closed Access
Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?
Georgios S. Papaetis, Michalis Picolos, Anastasia Sacharidou
Archives of Medical Science - Atherosclerotic Diseases (2025) Vol. 10, Iss. 1, pp. 1-15
Open Access
Georgios S. Papaetis, Michalis Picolos, Anastasia Sacharidou
Archives of Medical Science - Atherosclerotic Diseases (2025) Vol. 10, Iss. 1, pp. 1-15
Open Access
Treating Type 2 Diabetes With Early, Intensive, Multimodal Pharmacotherapy: Real-World Evidence From an International Collaborative Database
Matthew Anson, Ayesha Malik, Sizheng Steven Zhao, et al.
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-11
Open Access | Times Cited: 2
Matthew Anson, Ayesha Malik, Sizheng Steven Zhao, et al.
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-11
Open Access | Times Cited: 2
Role of epicardial adipose tissue in cardiac remodeling
Rongjun Zou, Miao Zhang, Weihui Lv, et al.
Diabetes Research and Clinical Practice (2024), pp. 111878-111878
Closed Access | Times Cited: 1
Rongjun Zou, Miao Zhang, Weihui Lv, et al.
Diabetes Research and Clinical Practice (2024), pp. 111878-111878
Closed Access | Times Cited: 1
Eficácia dos inibidores de SGLT2 no manejo da Doença Renal Crônica com ou sem Diabetes: resultados recentes e perspectivas
Maria Emília Oliveira de Queiroga, Mateus Werner Gabriel Valença Gomes, Éverton Victor Ferraz de Melo, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e72295-e72295
Open Access
Maria Emília Oliveira de Queiroga, Mateus Werner Gabriel Valença Gomes, Éverton Victor Ferraz de Melo, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e72295-e72295
Open Access
Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
Hye Soon Kim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 882-884
Closed Access
Hye Soon Kim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 882-884
Closed Access
